Showing posts with label musculoskeletal. Show all posts
Showing posts with label musculoskeletal. Show all posts
Saturday, March 31, 2012
Commentary: Aromatase inhibitors and musculoskeletal adverse events : The Lancet Oncology
Aromatase inhibitors and musculoskeletal adverse events : The Lancet Oncology
".........Because symptom collection is so variable between trials, researchers could look for correlations between changes in patient-reported quality of life and breast-cancer outcomes. Nevertheless, if clinical research confirms a link between emergent symptoms or changes in quality of life and breast-cancer outcomes, further pharmacogenomic and pharmacogenetic studies could help to elucidate the mechanisms. Although confirmation of the association between emergent symptoms with aromatase inhibitors and risk of breast-cancer recurrence would help to guide clinical advice, based on current evidence clinicians should not use the onset of musculoskeletal symptoms to infer which patient will, or will not, benefit from adjuvant treatment with aromatase inhibitors."
add your opinions
adverse effects
,
aromatase inhibitors
,
breast cancer
,
musculoskeletal
,
side effects
Subscribe to:
Posts
(
Atom
)